Signaling via the inducible costimulator ICOS fuels the stepwise development of follicular helper T cells (T FH cells). However, a signaling pathway unique to ICOS has not been identified. We found here that the kinase TBK1 associated with ICOS via a conserved motif, IProx, that shares homology with the tumor-necrosis-factor receptor (TNFR)-associated factors TRAF2 and TRAF3. Disruption of this motif abolished the association of TBK1 with ICOS, TRAF2 and TRAF3, which identified a TBK1binding consensus. Alteration of this motif in ICOS or depletion of TBK1 in T cells severely impaired the differentiation of germinal center (GC) T FH cells and the development of GCs, interfered with B cell differentiation and disrupted the development of antibody responses, but the IProx motif and TBK1 were dispensable for the early differentiation of T FH cells. These results reveal a previously unknown ICOS-TBK1 signaling pathway that specifies the commitment of GC T FH cells.
The diversification of antigen receptors in higher organisms is an evolutionary adaptation to the rapid mutability of the ever-evolving microorganisms. The ability to generate high-affinity neutralizing antibodies protects the host from invading pathogens. Nonetheless, the process of diversifying antigen receptors intrinsically carries the risk of recognition of self antigens, which leads to destruction of self tissues and autoimmune manifestations. One safeguard mechanism is insulation of the antibody-generating machinery in a specialized anatomical compartment, known as the 'germinal center' (GC), embedded within secondary lymphoid organs. Inside GCs, B cells undergo successive rounds of random somatic hypermutation, affinity maturation and isotype class switching 1 . Only B cells expressing high-affinity, class-switched antibodies specific for the immunizing antigen are 'licensed' to exit the GCs and to survive as long-lived plasma cells and/or memory B cells. Guiding B cells through these stochastic events is a subset of CD4 + helper T cells known as 'follicular helper T cells' (T FH cells) [2] [3] [4] .
In secondary lymphoid organs, B cells and T cells are organized in an orderly way into B cell follicles and T cell zones on the basis of gradients of the chemokines CXCL13 and CCL19-CCL21, respectively. The homing of T cells into B cell follicles requires concomitant high expression of the CXCL13-responding chemokine receptor CXCR5 and reduced expression of the CCL19-CCL21-binding chemokine receptor CCR7. This preconditioning process occurs at the priming stage during the interaction between dendritic cells and naive T cells 5 .
T cells conditioned to enter B cell follicles acquire a distinct transcriptional profile by upregulating their expression of Bcl6 (the canonical transcription factor of T FH cells) and repressing their expression of the transcription factor Blimp1 (refs. [6] [7] [8] . The CXCR5 + Bcl6 + CD4 + T cells (called 'nascent T FH cells' here), which appear as early as 2-3 d after viral infection or immunization with protein, migrate to the T cell-B cell border 9, 10 . At this site, contiguous interaction between CXCR5 + Bcl6 + nascent T FH cells and cognate B cells allows further maturation of T FH cells 11 . Fully mature T FH cells (called 'GC T FH cells' here) are crucial for the support of B cell responses. GC T FH cells are distinguishable from nascent T FH cells by their elevated expression of multiple markers, including the immunoregulatory receptor PD-1 (refs. 5,12,13) .
The receptor-ligand pair ICOS-ICOSL is quintessential throughout T FH cell development. Homozygous loss of ICOS is found in patients with common variable immunodeficiency and a concomitant decrease in CXCR5 + memory T FH cells 14, 15 . Similarly, Icos −/− mice and Icosl −/− mice have deformed GCs and impaired humoral responses and lack immunological memory [16] [17] [18] [19] . However, the molecular basis of the critical importance ICOS in the development and function of T FH cells remains relatively unclear. So far, phosphatidylinositol-3-OH kinase (PI3K) is the only signaling molecule known to interact with ICOS 20, 21 . However, PI3K associates with and signals from various other cell-surface receptors, including the costimulatory receptor CD28 and CTLA-4 (refs. [22] [23] [24] . Furthermore, several studies have A r t i c l e s revealed that disruption of the ICOS-PI3K interaction or selective deletion of PI3K components from T cells do not result in a complete phenocopy of Icos −/− mice [25] [26] [27] . Such studies indicate that unknown molecules could potentially mediate ICOS-dependent but PI3Kindependent signaling pathways.
Here we used a proteomics approach to identify previously unknown ICOS-interacting partners and explored their relevance in ICOS signaling that controls the development and function of T FH cells. We found that the cytoplasmic tail of ICOS has two novel evolutionarily conserved motifs. Proteomics and biochemical analyses revealed that the proximal motif of ICOS (the 'IProx motif ') physically recruited the serine-threonine kinase TBK1. Although the early polarization of nascent T FH cells was unperturbed, the differentiation of GC T FH cells and the development of B cell responses were significantly impaired in the absence of the IProx motif or after depletion of TBK1 in CD4 + T cells. Notably, the IProx motif was homologous to a conserved motif found in the tumor-necrosis-factor receptor (TNFR)-associated factors TRAF2 and TRAF3. As disruption of the shared motif in TRAF2 and TRAF3 abolished their association with TBK1, we have not only revealed a critical role for TBK1 in adaptive T cell immunity via its association with ICOS but also identified a TBK1-binding consensus sequence.
RESULTS
The IProx motif is required for GC T FH cell development Other than its PI3K-binding motif Tyr-x-x-Met (YxxM, where 'x' indicates any amino acid), the cytoplasmic tail of ICOS lacks known canonical motifs that mediate protein-protein interactions. To identify other potential binding sites, we performed sequence alignment of the cytoplasmic tail in orthologs of ICOS ( Supplementary  Fig. 1a ). Notably, this analysis revealed, in addition to the PI3Kbinding YxxM motif, two additional highly conserved motifs in the intracellular domain of ICOS (Fig. 1a) . The identification of the YxxM motif as one of the three conserved motifs confirmed our bioinformatics search. The other two conserved motifs were the SSSVHDPNGE motif (at positions 170-179) and the AVNTAKK motif (at positions 185-191) ( Fig. 1a and Supplementary Fig. 1a ). The conservation of these two motifs suggested that they might have important function(s) involving the recruitment of other molecule(s) that might mediate downstream ICOS signaling.
We focused on the proximal SSSVHDPNGE motif (the IProx motif). To investigate the physiological importance of this motif, we generated retroviral vectors that expressed wild-type ICOS or one of three ICOS mutants, with replacement of all residues in the IProx motif with a string of ten alanine residues (mIProx), substitution of phenylalanine for tyrosine at position 180 (Y180F) in the PI3K-binding site (YF), or deletion of the cytoplasmic tail (amino acid residues 170-200) to generate a 'tail-less' mutant (TL); the retroviral vectors also expressed green fluorescent protein (GFP) as a reporter. Each retroviral vector was used to reconstitute ICOS expression in CD4 + T cells from Icos −/− SMARTA mice (with transgenic expression of a T cell antigen receptor (TCR) specific for a peptide consisting of amino acids 61-80 lymphocytic choriomeningitis virus (LCMV) glycoprotein (gp61-80) presented by I-A b ). The reconstituted cells displayed similar surface expression of each transduced ICOS protein ( Supplementary Fig. 2a,b ). Sorted transduced (GFP + ) cells were adoptively transferred into C57BL/6 (B6) recipient mice and were analyzed 7 d after acute infection of the host mice with LCMV Armstrong strain. As expected, Icos −/− SMARTA CD4 + T cells reconstituted with wild-type ICOS differentiated into CXCR5 + SLAM lo T FH cells; in contrast, each of the three ICOS mutants failed to properly generate the CXCR5 + SLAM lo T FH cell population (Fig. 1b,c) . Additionally, we also assessed the presence of GC T FH cells, which have high expression of PD-1. The differentiation of CXCR5 + PD1 hi GC T FH cells was restored in Icos −/− SMARTA CD4 + T cells reconstituted with wild-type ICOS but remained significantly impaired after reconstitution with each of the three ICOS mutants ( Fig. 1d,e ). With the exception of the group reconstituted with TL mutant, we recovered similar numbers of transduced cells in all groups (Supplementary Fig. 3a) , which suggested that the defects observed were not due to differences in T cell proliferation and/or cell death. Together our data demonstrated that in addition to the PI3K-binding motif, the IProx motif was also required for T FH cell differentiation.
To further elucidate the physiological relevance of the IProx motif in B cell responses, we performed similar transfer of retrovirustransduced Icos −/− SMARTA CD4 + T cells into recipient mice with conditional deletion of Bcl6 specifically in CD4 + T cells (via deletion of loxP-flanked Bcl6 alleles (Bcl6 fl/fl ) by Cre recombinase expressed via the promoter, enhancer and silencer sequences of the T cellspecific gene Cd4). The Bcl6 fl/fl CD4-Cre + recipient mice are intrinsically unable to generate T cell-dependent B cell immunity 6, 28 . After the adoptive cell transfer, the host mice were immunized with keyhole limpet hemocyanin (KLH)-conjugated peptide of amino acids 61-80 of LCMV glycoprotein (KLH-gp61) and their responses were analyzed. The B cell responses of these mice were fully dependent on the ability of the transferred T cells to differentiate into GC T FH cells, as the mIProx, YF and TL ICOS mutants failed to restore this cell population ( Supplementary Fig. 4a,c) . As a benchmark for proper development of GC T FH cells, the transfer of Icos −/− SMARTA CD4 + T cells reconstituted with wild-type ICOS supported the differentiation of Fas + GL7 + GC B cells ( Fig. 1f,g) and IgD − CD138 + plasma cells ( Fig. 1h ,i) in response to immunization with KLH-gp61. In contrast, B cell differentiation was much lower in the absence of a functional IProx motif or PI3K-binding motif or in the complete absence of the ICOS intracellular tail, with GC B cell frequencies indistinguishable from those of mice that received Icos −/− SMARTA T cells reconstituted with the empty-vector control ( Fig. 1f-i) . Moreover, the immunoglobulin G (IgG) response to KLH-gp61 was greatly diminished in mice that received Icos −/− CD4 + T cells reconstituted with IProx, YF or TL mutant ICOS relative to that of mice that received Icos −/− CD4 + T cells reconstituted with wild-type ICOS (Fig. 1j) . The quantity of the antigen-specific IgG response was significantly and severely impaired in the absence of either IProx-dependent ICOS signaling or PI3K-dependent ICOS signaling ( Fig. 1k,l) . Therefore, the development of these antigen-specific T cell-dependent B cell responses required complete ICOS signaling that involved both the IProx motif and YxxM motif. These data established that the IProx motif was required for the in vivo differentiation of GC T FH cells.
Physical interaction of TBK1 with the IProx motif
To identify a putative molecule (or molecules) that might bind to the IProx motif, we undertook an unbiased proteomics approach using SILAC (stable isotope labeling by amino acids in cell culture), which allows quantitative comparative measurement of proteins. We costimulated cells expressing wild-type ICOS or the mIProx ICOS mutant with antibody to the TCR invariant chain CD3 (anti-CD3) plus anti-ICOS, immunoprecipitated proteins from the cells with anti-ICOS and analyzed the proteomes of the immunoprecipitates (called 'ICOS IPs' here). One cytosolic protein, TBK1, a non-canonical member of the inhibitor of transcription factor NF-κB kinase (IKK) family, had the greatest difference (approximately eightfold) in the ratio of its binding A r t i c l e s to ICOS in cells expressing wild-type ICOS to that in cells expressing mIProx ( Table 1) . TBK1 is critically required for production of type I interferons by innate immune cells 29 . However, the role of TBK1 in T cells has not been pinpointed.
To confirm the proteomics data, we performed a co-immunoprecipitation analysis and found that ICOS immunoprecipitated together with endogenous TBK1 in primary CD4 + T cells upon restimulation with anti-CD3 plus anti-ICOS ( Fig. 2a) . Moreover, TBK1 phosphorylated on its activating residue (Ser172) was detected in ICOS IPs ( Fig. 2a) , which suggested that ICOS was able to recruit the active form of TBK1. Subsequently, we transfected human Jurkat T cells to express wild-type ICOS or the mIProx, YF or TL ICOS mutant and analyzed the presence of TBK1 in ICOS IPs from stimulated cells. Wild-type ICOS interacted strongly with endogenous TBK1, but the interaction was much lower in cells expressing mIProx (Fig. 2b,c) , consistent with the proteomics data. Substitution of the tyrosine residue (the YF mutant) abolished the binding of p85α (the regulatory subunit of PI3K) without affecting the ICOS-TBK1 interaction, and the binding of p85α to ICOS was not impaired in cells transfected to express mIProx (Fig. 2b,c) . In addition, we determined that TBK1 associated only with ICOS but not with the closely related costimulatory receptors CD28 and CTLA-4 ( Fig. 2d) , which demonstrated that this signaling pathway was unique to ICOS.
To explore the physiological relevance of the ICOS-TBK1 interaction, we studied human GC T FH cells. There was basal interaction between ICOS and TBK1 in unstimulated human GC T FH cells ( Fig. 2e) . The interaction of TBK1 with ICOS was further strengthened upon stimulation with anti-CD3 plus anti-ICOS ( Fig. 2e) , which suggested that the ICOS-TBK1 interaction in GC T FH cells was inducible via inputs from the TCR and ICOS. Together these data indicated that ICOS physically interacted with active TBK1 via the conserved IProx motif in T FH cells.
Importance of TBK1 for the development of GC T FH cells
Since we demonstrated that the IProx motif was required for T FH cell development ( Fig. 1 ) and that this motif physically interacted with TBK1 ( Fig. 2) , we hypothesized that TBK1 has a role in the differentiation of T FH cells. To test this hypothesis, we used a knockdown strategy based on RNA-mediated interference with short hairpin RNA (shRNA). LCMV-glycoprotein-specific SMARTA CD4 + T cells were retrovirally transduced with shRNA targeting Tbk1 (shTbk1-1 or shTbk1-2; Supplementary Fig. 2c ). In parallel, we used non-targeting shRNA (shControl) as a negative control and shRNA targeting Icos (shIcos) as a positive control. Transduced SMARTA CD4 + T cells were adoptively transferred into B6 mice and analyzed 7 d after infection of the host mice with LCMV to assess the effects of depletion of TBK1 on GC T FH cell development. npg A r t i c l e s Depletion of ICOS in SMARTA CD4 + T cells significantly diminished the CXCR5 + SLAM lo T FH cell population, as well as the CXCR5 + PD1 hi and CXCR5 + GL-7 + GC T FH cell populations ( Fig. 3a-f) . Notably, knockdown of Tbk1 in SMARTA CD4 + T cells also significantly impaired the full development of GC T FH cells ( Fig. 3a-f ), which demonstrated that TBK1 was critical for full commitment to T FH cell differentiation. The abundance of Tbk1 transcripts was reduced by ~75% in vivo in sorted cells transduced with shTbk1-1 or shTbk1-2 relative to that in cells transduced with shControl or shIcos ( Supplementary Fig. 2e,g) , and they accumulated in vivo to an extent similar to that of cells transduced with shControl ( Supplementary Fig. 3b) .
To assess the physiological relevance of TBK1 in T cell-dependent B cell responses, we immunized Bcl6 fl/fl CD4-Cre + mice with KLH-gp61 and assessed their GC and antibody responses. The differentiation of CXCR5 + PD1 hi GC T FH cells was substantially impaired in the presence of shTbk1-1 or shTbk1-2, consistent with the results obtained by acute viral infection ( Supplementary Fig. 4b,d ). The frequency of Fas + PNA + GC B cells was significantly reduced in mice that received SMARTA CD4 + T cells with depletion of TBK1 ( Fig. 3g,h) .
IgG responses specific for KLH-gp61 were also significantly impaired after depletion of ICOS or TBK1 ( Fig. 3i-k) . The titers of IgG directed against KLH-gp61 were about tenfold lower in the absence of an intact ICOS-TBK1 signaling pathway than in the presence of this pathway ( Fig. 3j) . Concomitantly, the architecture of PNA + GCs was severely compromised in mice that received cells transduced with shIcos, shTbk1-1 or shTbk1-2 relative to that of mice that received cells transduced with shControl ( Fig. 3l) . Thus, TBK1 in CD4 + T cells was needed to support T FH cells differentiation and the development of GC and antigen-specific T cell-dependent IgG responses.
Dispensability of IProx for the development of nascent T FH cells
The complete programming of T FH cells is a multistep process that involves T cell-dendritic cell interaction at the early stage and T cell-B cell interaction at a later phase 9, 30, 31 . To assess the importance of the IProx motif in the differentiation of nascent T FH cells, we carried out a reconstitution experiment similar to that described above ( Fig. 1) and performed the analysis earlier, at 3 d after infection with LCMV. As expected, Icos −/− SMARTA CD4 + T cells reconstituted with wild-type ICOS were able to differentiate into CXCR5 + Bcl6 + nascent T FH cells ( Fig. 4a,b) . However, unexpectedly, Icos −/− SMARTA CD4 + T cells reconstituted with mIProx were equally able to polarize into nascent T FH cells (Fig. 4a,b) . Additionally, the expression of Bcl6 protein was similar in T cells reconstituted with wild-type ICOS and those reconstituted with mIProx ( Fig. 4c) , which indicated that the early expression of Bcl6 and potentially its regulatory functions were independent of the IProx motif.
Downregulation of CD25 expression is an additional characteristic of early T FH cell programming 9 . The CXCR5 + CD25 lo nascent T FH cell population was similar among Icos −/− SMARTA CD4 + T cells reconstituted with wild-type ICOS and those reconstituted with mIProx ( Fig. 4d,e ). However, mice that received Icos −/− SMARTA CD4 + T cells reconstituted with the YF or TL ICOS mutant had a smaller population of nascent T FH cells, identified by CXCR5 + Bcl6 + or CXCR5 + CD25 lo phenotyping, than that of mice that received Icos −/− SMARTA CD4 + T cells reconstituted with wild-type ICOS (Fig. 4d,e) , and also had lower expression of Bcl6 in the SMARTA cells than that of mice that received Icos −/− SMARTA CD4 + T cells reconstituted with wild-type ICOS (Fig. 4c) . Furthermore, we performed Mass-spectrometry analysis of the binding of various proteins (left) to ICOS in ICOS IPs of Jurkat T cells transfected to express wild-type ICOS or mIProx, then stimulated with anti-CD3 plus anti-ICOS and metabolically labeled, showing only proteins identified with more than four different peptides and with a significant (P < 0.05) difference of >1.5-fold in binding to ICOS in cells expressing wild-type ICOS relative to that in cells expressing mIProx (WT/mIProx). Data are pooled from four independent experiments. npg A r t i c l e s immunofluorescence histology to quantify the congenic CD45.1 + Icos −/− SMARTA T cells reconstituted with wild-type ICOS or mIProx in B cell follicles of the host CD45.2 + B6 mice. There was no significant difference between cells reconstituted with wild-type ICOS and those reconstituted with mIProx in terms of their abundance in the B cell follicles ( Fig. 4f) , consistent with hypothesis that the differentiation and migration of nascent T FH cells is independent of the ICOS-TBK1 pathway. Thus, the differentiation of nascent T FH cells occurred in the absence of the IProx motif. However, the subsequent maturation of T FH cells was blocked in the absence of this ICOS-mediated pathway. Together these results showed that the ICOS-PI3K pathway regulated the very early stage of T FH cell polarization, whereas the signaling emanating from the IProx motif was critically required for the progression of nascent T FH cells to GC T FH cells.
Dispensability of TBK1 for the development of nascent T FH cells
To further delineate the role of TBK1 in T FH cell development, we tracked the development of the nascent T FH cells among T cells depleted of TBK1, similar to that described above (Fig. 3) , and performed the analysis at an earlier time point, at 3 d after infection with LCMV. Knockdown of Icos in SMARTA CD4 + T cells significantly impeded their differentiation into nascent T FH cells relative to that of SMARTA CD4 + T cells transduced with shControl ( Fig. 5a,b) . The differentiation of CXCR5 + Bcl6 + nascent T FH cells was not affected in cells transduced with shTbk1-1 or shTbk1-2 ( Fig. 5a,b) . Commensurate with those findings, there was no significant difference between SMARTA CD4 + T cells transduced with shControl and those transduced with shTbk1-1 or shTbk1-2 in their expression of Bcl6 protein (Fig. 5c) . Analysis of the nascent T FH cells with additional markers (i.e., as CXCR5 + CD25 lo or CXCR5 + SLAM lo cells) produced comparable results (Fig. 5d,e and Supplementary Fig. 5a,b) . Furthermore, we did not observe any difference in the expression of CXCR5, TCR, CD28 or CD40L (ligand for the costimulatory receptor CD40) in SMARTA CD4 + T cells transduced with shControl and those transduced with shTbk1-1 or shTbk1-2 ( Supplementary Fig. 5c-f) . The efficiency of knockdown of Tbk1 mRNA in vivo at 3 d after infection was ~80% npg A r t i c l e s ( Supplementary Fig. 2d,f) . In agreement with the mIProxreconstitution data (Fig. 4) , knockdown of Tbk1 in SMARTA CD4 + T cells did not interfere with the early differentiation of nascent T FH cells (Fig. 5) . Therefore, signals mediated by binding of TBK1 to the IProx motif 'licensed' nascent T FH cells to enter the GC phase of T FH cell development.
Molecular basis of the ICOS-TBK1 interaction
Because the ICOS-PI3K and ICOS-TBK1 pathways exhibit distinct activity in the priming and GC stages of T FH cell development, we hypothesized that the two pathways might be activated by different stimulating signals. To investigate this hypothesis, we stimulated CD4 + T cells in the presence of anti-CD3 alone, anti-ICOS alone, or a combination of both, to mimic TCR signaling, ICOS-ICOSL signaling, or the simultaneous activation of both signals, respectively.
We then analyzed the association of ICOS with either p85α or TBK1 under these conditions. In the absence of stimulation, ICOS did not immunoprecipitate together with p85α, but the ICOS-p85α association was induced rapidly by all three forms of stimulation (Fig. 6a) . Strikingly, and in contrast to those results, TBK1 immunoprecipitated together with ICOS only when the cells were costimulated with anti-CD3 plus anti-ICOS, but not under conditions of no stimulus or when single stimuli were applied (Fig. 6a) . These results indicated that combined signaling from the TCR and ICOS was needed to induce the ICOS-TBK1 association. Additionally, in CD4 + T cells, the phosphorylation of TBK1 was induced only in the presence of a strong anti-CD3 signal plus anti-ICOS signal (Fig. 6b) , in supporting of the idea that strong TCR stimulation favors a TBK1-dependent signal to drive the differentiation of GC T FH cells 32 . Thus, the requirement for the activation of ICOS-TBK1 signaling was more stringent than npg A r t i c l e s that for the ICOS-PI3K pathway in that it required two simultaneous signals provided by the strong cognate interaction between T cells and antigen-presenting cells. TBK1 transduces pivotal signals from TNFR and Toll-like receptor (TLR) molecules 29 . TRAF proteins, particularly TRAF2, TRAF3 and TRAF5 (but not TRAF6), can physically interact with TBK1 to mediate the downstream effector functions 33, 34 , although the TBK1binding motif in TRAF proteins has not been defined. We were not able to detect co-immunoprecipitation of TRAF2, TRAF3 or TRAF5 with ICOS in T cells (Supplementary Fig. 6) , consistent with the fact that ICOS does not belong to the TNFR superfamily or TLR superfamily. Additionally, IKKε, which forms a complex with TBK1 (refs. 35, 36) , was also absent from the immunoprecipitated ICOS signalosome ( Supplementary Fig. 6) , which supported the possibility that the ICOS-TBK1 pathway was mechanistically distinct from the TNFR or TLR pathways. We speculated that instead of recruiting TBK1 via TRAF proteins, perhaps ICOS itself might contain a motif shared with TBK1-binding TRAF proteins. To test this, we performed a BLASTp analysis (with the basic local alignment search tool for proteins) comparing the human ICOS cytoplasmic tail and full-length TRAF2 and TRAF3. Unexpectedly, this analysis revealed substantial homology between the IProx motif and a region of TRAF2 and TRAF3 known as the 'serine tongs' 37 (Fig. 6c) . This region (SSSxxxPxGD/E, where 'S' is serine, 'x' is any amino acid, 'P' is proline, 'G' is glycine and 'D/E' indicates aspartic acid or glutamic acid) was present in TRAF2, TRAF3 and TRAF5 (which are the TRAF proteins known to bind TBK1) but not in TRAF4 or TRAF6 (Fig. 6c) . Additionally, this extended 'serine tongs' motif was also well conserved among TRAF2 and TRAF3 orthologs throughout evolution (Supplementary Fig. 1b,c) .
The homology between ICOS and TRAF proteins suggested that the shared motif might be a consensus TBK1-binding motif. To confirm that, we substituted the corresponding region in TRAF2 (residues 453-462) and TRAF3 (residues 518-527) with a string of ten alanine residues and assessed the interaction of these TRAF mutants with TBK1. While TBK1 interacted strongly with wild-type TRAF2 (Fig. 6d) and wild-type TRAF3 (Fig. 6e) , its association with the corresponding mutant TRAF proteins was much lower (Fig. 6d,e) , similar to the defective association of TBK1 with the mIProx (Fig. 2b) . Therefore, these results supported the idea that the IProx motif by itself acted as a TBK1-binding site on ICOS and thus bypassed the requirement for TRAF molecules as intermediary partners.
DISCUSSION
CD4 + T cells undergo sequential phases of differentiation and maturation to become mature 'bona fide' GC T FH cells. ICOS signaling has a critical role in T FH cell development, and the only protein known thus far to interact with the cytoplasmic tail of ICOS in an inducible manner is PI3K. However, published studies have demonstrated that several ICOS-mediated T cell functions are independent of PI3K signaling [25] [26] [27] , indicative of the existence of additional ICOS signaling pathways. Here we have elucidated a signaling pathway emanating from ICOS that was critical for the full maturation of GC-residing T FH cells. Specifically, we have identified a previously unknown, evolutionarily conserved membrane-proximal ICOS motif, IProx, that was required for the development and function of T FH cells, and have identified TBK1 as an activation-induced interacting partner of this motif; we have demonstrated that the recruitment of TBK1 to ICOS was required for the development of GC T FH cells, while it was npg A r t i c l e s dispensable for the differentiation of nascent T FH cells; and we have identified a TBK1-binding consensus sequence that was shared by the IProx motif, TRAF2 and TRAF3. TBK1 is essential for the production of type I interferons in innate immune cells 35, 36 . Additionally, TBK1 also has a role in non-immune cells 38 and in B cells 39 , as well as in immune responses to DNA vaccines 40 . TBK1 has been found to interact with TRAF2 and to activate NF-κB signaling 41 . Subsequently, TRAF3, but not TRAF6, was shown to bind TBK1 (refs. 33, 42) . However, the actual motif in TRAF2 and TRAF3 required for binding TBK1 has not been definitively mapped. Here we mapped the TBK1-binding site to the IProx motif and found that this motif was also present in TBK1-binding TRAF proteins. This TRAF 'serine tongs' motif was initially proposed to function as a TRAF2-binding site for the cytoplasmic domain of CD40 (ref. 37 ), but subsequent analyses failed to confirm that hypothesis 43 . Thus, the role of the highly conserved 'serine tongs' motif in TRAF2 and TRAF3 has remained controversial. Our findings suggest that the SSSxxxPxGD/E IProx motif represents the canonical TBK1-binding sequence.
Initial signals required for the polarization of nascent T FH cells include those from the CD28-B7 receptor-ligand pair 44, 45 and ICOS-ICOSL 9, 46 . Published studies have circumstantially linked these early events to the PI3K-mediated ICOS pathway 9, 25 . Moreover, stimulation with ICOS induces the interaction of PI3K with intracellular osteopontin, which results in interaction of osteopontin with Bcl6 and protection of osteopontin from degradation. Ablation of intracellular osteopontin leads to failure of the maintenance of Bcl6 as early as 3 d after immunization with protein 47 . Our finding that alteration of the PI3K-binding site in ICOS hindered the polarization of nascent T FH cells and significantly compromised early expression of Bcl6 protein was fully consistent with the studies discussed above.
Our study has revealed a previously unknown molecular pathway (the TBK1-dependent pathway mediated by the IProx motif) that functioned to drive the differentiation of T cells from the nascent T FH cell stage to the mature GC T FH cell stage. Nascent T FH cells are the precursors of true GC T FH cells. Only after contact with cognate B cells do these nascent T FH cells receive additional maturation signals to become CXCR5 + PD1 hi GC T FH cells. GC T FH cells fail to develop in the absence of B cells 5, 6, 11 , after B cell-specific conditional deletion of ICOSL 48 or following blockade with anti-ICOSL 9 , which indicates that ICOS-ICOSL engagement mediated by cognate T cell-B cell interaction is essential for the continuous maturation of these interacting cells. Published data have also shown that ICOS-driven motility, which promotes the migration of T FH cells deep into the follicular parenchyma, can also be dependent on ICOS-coupled PI3Kmediated signaling triggered by ICOSL present on bystander follicular B cells, which do not present cognate antigen 49 .
Our findings demonstrating a role for distinct ICOS-linked signaling modules in full T FH cell differentiation can potentially unify those seemingly opposing observations, since we have shown that while stimulation via either TCR or ICOS alone was able to induce the association of ICOS with PI3K, a combination of both signals was needed to recruit and activate TBK1. Therefore, it could be argued that upon encountering B cells expressing complexes of cognate peptide and major histocompatibility complex molecules and ICOSL, ICOS-TBK1 signaling, possibly in conjunction with ICOS-PI3K pathway, induces the maturation process of nascent T FH cells. After that differentiation step, mature T FH cells might migrate into the follicular parenchyma through serial interactions with bystander follicular B cells in a manner dependent on the ICOS-ICOSL interaction 49 but independent of TCR signals, which would be sufficient to trigger the ICOS-PI3K signaling pathway. Consistent with that, we found that there was no defect in the early migration of T FH cells in the absence of ICOS-TBK1 pathway but that the nascent immature T FH cells that infiltrated into B cell follicles were unable to support B cell maturation and GC development. Therefore, there was a bifurcation in functionality between the IProx-motif dependent ICOS-TBK1 pathway and the ICOS-PI3K pathway. Our data demonstrated that both pathways were essential, independently, for T FH cell differentiation, GC development and the IgG response.
Antibody production is a 'double-edged' process. CD4 + T FH cells are endowed with the ability to positively support the maturation of B cells producing antibodies with the highest affinity for the immunizing antigen while counter-selecting for B cells expressing self-reactive antibodies. Here we showed that ICOS regulated a previously unknown TBK1-dependent signaling pathway that was needed to allow the commitment of cells to become fully functional GC T FH cells. Therefore, our findings expand the essential roles of TBK1 to antigen-specific CD4 + T cell immunity. Strategic manipulation of these ICOS-dependent pathways might lead to better vaccine design and treatment of autoimmune diseases.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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